TEMN3-AS1

Across TCGA pan-cancer cohorts, TEMN3-AS1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated TEMN3-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher TEMN3-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TEMN3-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.

BLCA, SKCM, and COAD are the cancer types where TEMN3-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.230	0.556	<.001	114	view →
SKCM	OS	Tertile	III,IV	0.496	0.726	.003	69	view →
COAD	DFS	Tertile	All	0.196	0.699	.001	60	view →
MESO	OS	Tertile	All	0.144	0.557	.029	45	view →
STAD	DFS	Tertile	All	0.290	0.729	<.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
THYM	DFS	Tertile	All	0.410	0.878	<.001	27	view →
ACC	DFS	Tertile	All	0.068	0.623	.015	18	view →
TGCT	DFS	Tertile	All	0.346	0.689	.010	18	view →
KIRP	OS	Tertile	All	0.608	0.903	.016	18	view →
PAAD	DFS	Tertile	II,III,IV	0.305	0.276	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

TEMN3-AS1–BLCA (DFS)

Open the BLCA breakdown →